Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial.
Robledo KP, Marschner IC, Handelsman DJ, Bracken K, Stuckey BGA, Yeap BB, Inder W, Grossmann M, Jesudason D, Allan CA, Wittert G. Robledo KP, et al. Among authors: bracken k. Eur J Endocrinol. 2023 Jul 10;188(7):613-620. doi: 10.1093/ejendo/lvad074. Eur J Endocrinol. 2023. PMID: 37406250 Clinical Trial.
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trial.
Wittert G, Atlantis E, Allan C, Bracken K, Conway A, Daniel M, Gebski V, Grossmann M, Hague W, Handelsman DJ, Inder W, Jenkins A, Keech A, McLachlan R, Robledo K, Stuckey B, Yeap BB. Wittert G, et al. Among authors: bracken k. Diabetes Obes Metab. 2019 Apr;21(4):772-780. doi: 10.1111/dom.13601. Epub 2019 Jan 4. Diabetes Obes Metab. 2019. PMID: 30520208
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trial.
Bracken K, Keech A, Hague W, Kirby A, Robledo KP, Allan C, Conway A, Daniel M, Gebski V, Grossmann M, Handelsman DJ, Inder W, Jenkins A, McLachlan R, Stuckey B, Yeap BB, Wittert G. Bracken K, et al. J Clin Epidemiol. 2019 Aug;112:45-52. doi: 10.1016/j.jclinepi.2019.04.009. Epub 2019 Apr 30. J Clin Epidemiol. 2019. PMID: 31051248 Clinical Trial.
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, Stuckey B, Conway A, Inder W, McLachlan R, Allan C, Jesudason D, Fui MNT, Hague W, Jenkins A, Daniel M, Gebski V, Keech A. Wittert G, et al. Among authors: bracken k. Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45. doi: 10.1016/S2213-8587(20)30367-3. Lancet Diabetes Endocrinol. 2021. PMID: 33338415 Clinical Trial.
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT.
Ng Tang Fui M, Hoermann R, Bracken K, Handelsman DJ, Inder WJ, Stuckey BGA, Yeap BB, Ghasem-Zadeh A, Robledo KP, Jesudason D, Zajac JD, Wittert GA, Grossmann M. Ng Tang Fui M, et al. Among authors: bracken k. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3143-e3158. doi: 10.1210/clinem/dgab149. J Clin Endocrinol Metab. 2021. PMID: 33693907 Clinical Trial.
44 results